FindTrial
Sign In

Clinical observation and retrospective analysis of the effect of HR positive breast cancer patients on hepatic hemangioma after comprehensive treatment: clinical observation and retrospective study

Clinical observation and retrospective analysis of the effect of HR positive breast cancer patients on hepatic hemangioma after comprehensive treatmentr: a retrospective study

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000033089
Enrollment
Unknown
Registered
2020-05-20
Start date
2020-05-19
Completion date
Unknown
Last updated
2020-05-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatic Hemangioma

Interventions

case series:N/A

Sponsors

Yunnan Cancer Hospital
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: 1. Patients aged >= 18 and = 1cm; 4. Patients with good liver function and child Pugh a; 5. The patient is generally in good condition, and the cardiopulmonary function can tolerate surgery.

Exclusion criteria

Exclusion criteria: 1. Patients with incomplete follow-up data; 2. Patients with a history of upper abdominal surgery; 3. Patients who have been treated for hemangioma of liver; 4. Patients with liver cancer; 5. Patients with blood system diseases.

Design outcomes

Primary

MeasureTime frame
Size of Hemangioma of liver;—

Countries

China

Contacts

Public ContactChen WenLin

Yunnan Cancer Hospital

chenwenlin@aliyun.com+86 13888087395

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026